| Related Articles |
Medication Effects on EEG Biomarkers in Attention-Deficit/Hyperactivity Disorder.
Clin EEG Neurosci. 2016 Oct 25;:
Authors: Isiten HN, Cebi M, Sutcubasi Kaya B, Metin B, Tarhan N
Abstract
EEG biomarkers have become increasingly used to aid in diagnosis of attention-deficit/hyperactivity disorder (ADHD). Despite several studies suggesting that EEG theta/beta ratio may help discriminating ADHD from other disorders, the effect of medications on theta/beta ratio is not known. Forty-three children with ADHD that were evaluated with quantitative EEG before and after methylphenidate were included in the study. Theta/beta ratio, theta and beta powers for whole brain, central, and frontal areas were calculated. Theta/beta power decreased significantly after treatment; however, this change was largely due to an increase in beta power, rather than a fall in theta power. The results suggest that beta power is sensitive to medication effects, while theta power remains as a trait biomarker unaffected by medication status. The value of EEG biomarkers for monitoring neuropsychological performance and clinical status should be explored by future studies.
PMID: 27798290 [PubMed – as supplied by publisher]
via https://www.ncbi.nlm.nih.gov/pubmed/27798290?dopt=Abstract
